Home Search

chemotherapy - search results

If you're not happy with the results, please do another search
personalised nanomedicine

Cutting-edge technology synergy in the personalised nanomedicine space: Focus on pharmaceutical nanomanufacturing

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explains cutting-edge technology synergy in the personalised nanomedicine space, with a special focus on pharmaceutical nanomanufacturing
acute myeloid leukaemia

Living with acute myeloid leukaemia (AML)

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores the challenges of living with acute myeloid leukaemia (AML)

Aplastic anaemia and other rare bone marrow failures

Grazina Berry from Aplastic Anaemia Trust argues that young patients diagnosed with aplastic anaemia (AA) and other rare bone marrow failures need more help and support

Improving the care of children in Europe with rare cancer

The European Society for Paediatric Oncology together with Coordinators for the PARTNER Project and ERN PaedCan highlight the importance of collaboration in order to improve the care of children in Europe with rare cancer
Antiviral and antitumor therapies

Antiviral and antitumor therapies

Prof Dr Chris Meier at the University of Hamburg, Faculty of Sciences, Department of Chemistry explores antiviral and antitumor therapies. He discusses the intracellular delivery of antivirally active nucleoside triphosphates and argues that the ultimate challenge is applying these as chemotherapeutics
cancer diagnosis

New data reveals cancer diagnosis could affect treatment options

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.
curing cancer

The challenge of curing cancer in the world’s children

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children
acute myeloid leukaemia

Improving acute myeloid leukaemia (AML) outcomes

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved
disease-associated myosteatosis fish oil

Disease-associated myosteatosis in people with cancer: Can it be treated?

Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...

Cancer immunotherapy therapy is here and now

Stephanie K. Watkins PhD from Loyola University Chicago shares her views on cancer immunotherapy therapy – the concept of using the immune system to fight and destroy cancer cells
thalassemia

Is 2018 the year we will see a cure for Thalassemia?

Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations
biomedical imaging

The role of advanced technologies in healthcare

The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government
Cancer research and training

Cancer research and training in the United States

The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government

The illusion of cancer and death: Illusion of the self

Sumith A Kularatne, PhD, discusses his thoughts on the illusion of cancer and death
Experimental Pathology Service - Institute of Pathology

Paediatric sarcoma metastasis: an area that warrants in-depth exploration

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...
stem cells

From wheelchair to high heels: Realising the potential of stem cells

Dr Michael A Rudnicki, CEO & Scientific Director at the Stem Cell Network gives an expert view on a new era in health care, powered by stem cells
acute leukaemia

Acute leukemia – driving toward precision and targeted medicine

Eigil Kjeldsen from Aarhus University Hospital gives an expert perspective on the drive towards precision and targeted medicine for acute leukaemia
chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML): Leukaemia patients watching and worrying

Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients
brain cancer

Zika virus could help combat brain cancer

New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults
care in oncology

Need for supportive care in oncology will increase during the next decade

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic disease Supportive care increases patient quality of life, improves their chances of completing treatment, can reduce costs for healthcare institutions, and is fundamentally necessary given that...

Follow Us

Advertisements